Table 3.
20% of protein n = 10 (control group) | 20% of protein + + vitamin B12 n = 10 | 4.5% of protein n = 10 | 4.5% of protein + + vitamin B12 n = 10 | |
---|---|---|---|---|
Monocytes (× 103/µl) | 0.51 ±0.07 | 0.4 ±0.06 | 0.29 ±0.04a | 0.55 ±0.08b |
Monocytes (%) | 5.0 ±0.8 | 4.1 ±0.4 | 3.9 ±0.4 | 4.5 ±0.4 |
Neutrophils (× 103/µl) | 0.9 ±0.1 | 0.9 ±0.1 | 1.3 ±0.1a | 1.80.3a |
Neutrophils (%) | 8.5 ±0.9 | 9.8 ±1.0 | 19 ±1.5a | 14.7 ±1.2a |
Eosinophils (× 103/µl) | 0.13 ±0.01 | 0.14 ±0.01 | 0.06 ±0.01a | 0.10 ±0.01a |
Eosinophils (%) | 1.3 ±0.2 | 1.4 ±0.1 | 0.9 ±0.1a | 0.8 ±0.1a |
Lymphocytes (× 103/µl) | 8.9 ±0.6 | 8.6 ±0.6 | 5.43 ±0.6a | 9.4 ±0.8b |
Lymphocytes (%) | 85.2 ±1.5 | 84.6 ±1.3 | 76.2 ±1.6a | 80.0 ±1.3 |
(B cells) CD45a+ (× 103/µl) | 2.4 ±0.2 | 2.3 ±0.2 | 1.0 ±0.1a | 2.2 ±0.2b |
(B cells) CD45a+ (%) | 26.8 ±1.3 | 26.6 ±0.8 | 18.3 ±1.1a | 23.6 ±1.2b |
(T cells) CD3+ (× 103/µl) | 5.3 ±0.5 | 4.9 ±0.5 | 3.7 ±0.4a | 5.9 ±0.5 |
(T cells) CD3+ (%) | 58.7 ±1.9 | 56.2 ±2.1 | 67.8 ±1.2a | 62.2 ±1.7 |
CD4+ (× 103/µl) | 3.7 ±0.3 | 3.4 ±0.4 | 2.7 ±0.2a | 4.3 ±0.3b |
CD4+ (%) | 41.2 ±0.2 | 39.4 ±2.0 | 49.6 ±1.3a | 45.4 ±1.1 |
CD8+ (× 103/µl) | 1.9 ±0.2 | 1.6 ±0.2 | 1.1 ±0.1a | 1.7 ±0.2b |
CD8+ (%) | 20.5 ±1.0 | 18.4 ±1.0 | 19.4 ±0.7 | 18.3 ±0.7 |
CD4/CD8 ratio | 2.0 ±0.1 | 2.1 ±0.1 | 2.6 ±0.1a | 2.5 ±0.1a |
NK cells (CD161 + ) (× 103/µl) | 0.37 ±0.05 | 0.33 ±0.04 | 0.25 ±0.04a | 0.37 ±0.04b |
NK cells (CD161 + ) (%) | 4.3 ±0.5 | 4.0 ±0.6 | 4.9 ±0.6 | 4.0 ±0.3 |
NKT cells (CD161+, CD3 + ) (× 103/µl) | 0.13 ±0.01 | 0.13 ±0.01 | 0.07 ±0.01a | 0.12 ±0.01b |
NKT cells (CD161+, CD3 + ) (%) | 1.4 ±0.1 | 1.5 ±0.1 | 1.3 ±0.1 | 1.2 ±0.1 |
Comparison to the control group
Comparison to 4.5% of protein group